Elevated CTLA-4 expression on CD4 T cells from periodontitis patients stimulated with Porphyromonas gingivalis outer membrane antigen

Clin Exp Immunol. 2000 Feb;119(2):280-6. doi: 10.1046/j.1365-2249.2000.01126.x.

Abstract

To characterize the T cell response to Porphyromonas gingivalis, we examined the expression of costimulatory molecules on T cells derived from adult periodontitis patients with high serum antibody titre to P. gingivalis. The expression of CD28, CTLA-4, CD40 ligand (CD40L) on CD4+ T cells was analysed by flow cytometry. IL-10 and transforming growth factor-beta (TGF-beta) mRNA expression were determined by reverse transcription-polymerase chain reaction (RT-PCR) and subsequent image analysis. Peripheral blood mononuclear cells (PBMC) derived from periodontitis patients showed higher proliferative responses to P. gingivalis outer membrane (OM) than those from healthy controls (P < 0.05). The percentage of CTLA-4+ cells within CD4+ T cells of patients was significantly higher than that of healthy controls after P. gingivalis OM stimulation (33.0% versus 11.9%, P < 0.01). There was no significant difference in the percentages of CD28+ cells and CD40L+ cells, and the percentage of CD40L+ cells was low in both groups even after stimulation. Stimulation of PBMC with P. gingivalis OM induced significantly higher IL-10 mRNA expression in periodontitis patients than in healthy controls (P < 0.05). The level of TGF-beta mRNA expression of patients tended to be higher than that of healthy controls, but there was no significant difference. To elucidate the functional role of CTLA-4, we further investigated the secondary proliferative response to P. gingivalis OM. Interestingly, P. gingivalis OM stimulation did not enhance antigen-specific secondary response. Anti-CTLA-4 MoAb had no effect on proliferation in the presence of P. gingivalis OM. CTLA-4Ig suppressed the proliferative response significantly (P < 0.01). These results suggest that T cell responses to P. gingivalis OM may be regulated by CTLA-4 that is expressed at the late phase of T cell activation, and, in part, immunosuppressive cytokines. Taken together, CTLA-4 may play a crucial role in the pathogenesis of chronic inflammatory periodontal disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abatacept
  • Adult
  • Antigens, Bacterial / immunology*
  • Antigens, CD
  • Antigens, Differentiation / biosynthesis*
  • Antigens, Differentiation / blood
  • Antigens, Differentiation / immunology
  • Bacterial Outer Membrane Proteins / immunology*
  • Bacteroidaceae Infections / immunology*
  • CD4-Positive T-Lymphocytes / immunology
  • CD4-Positive T-Lymphocytes / metabolism*
  • CTLA-4 Antigen
  • Cytokines / biosynthesis
  • Cytokines / genetics
  • Humans
  • Immunoconjugates*
  • Lymphocyte Activation / immunology
  • Middle Aged
  • Periodontitis / immunology*
  • Periodontitis / metabolism
  • Porphyromonas gingivalis / immunology*
  • RNA, Messenger / biosynthesis

Substances

  • Antigens, Bacterial
  • Antigens, CD
  • Antigens, Differentiation
  • Bacterial Outer Membrane Proteins
  • CTLA-4 Antigen
  • CTLA4 protein, human
  • Cytokines
  • Immunoconjugates
  • RNA, Messenger
  • Abatacept